Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F9H39
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,735
Award facts
- Contract value 100% obligated
- $21,734.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $21,734.84. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 21, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and other allergic inflammatory conditions, making this procurement part of the Defense Health Agency's pharmaceutical supply chain supporting military medical facilities.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and holds significant capacity to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's competitively awarded contracts with DLA demonstrate its capability to fulfill diverse pharmaceutical requirements for military healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F9H39?
SPE2DR26F9H39 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F9H39 worth?
The government has obligated $21,735 on SPE2DR26F9H39.
Is contract SPE2DR26F9H39 an order under another contract?
Yes. SPE2DR26F9H39 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9H39 competed?
The extent of competition for SPE2DR26F9H39 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award